Patent - Abbreviated New Drug Application Cases
Cases 1 - 10 of 89
Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals Inc.
as 1:2024cv00036
Plaintiff: Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc.
Defendant: Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals, Ltd. v. Mylan Pharmaceuticals Inc.
as 24-1641
Plaintiff: ACTELION PHARMACEUTICALS, LTD.
Defendant: MYLAN PHARMACEUTICALS INC.
Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc.
as 1:2024cv00050
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Defendant: Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Heron Therapeutics, Inc. v. Mylan Pharmaceuticals Inc.
as 1:2024cv00043
Plaintiff: Heron Therapeutics, Inc.
Defendant: Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals Ltd. et al v. Mylan Pharmaceuticals Inc.
as 1:2023cv00088
Plaintiff: Actelion Pharmaceuticals Ltd. and Actelion Pharmaceuticals US, Inc.
Defendant: Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Heron Therapeutics, Inc. v. Mylan Pharmaceuticals Inc.
as 1:2023cv01015
Plaintiff: Heron Therapeutics, Inc.
Defendant: Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc.
as 23-2260
Plaintiff / Appellant: NOVARTIS PHARMACEUTICALS CORPORATION
Defendant / Appellee: MYLAN PHARMACEUTICALS INC.
Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc.
as 23-2254
Plaintiff / Appellee: MERCK SHARP & DOHME B.V. and MERCK SHARP & DOHME, LLC
Defendant / Appellant: AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA LTD., USV PRIVATE LIMITED and others
Defendant: LUPIN LTD., LUPIN PHARMACEUTICALS, INC. and LUPIN INC.
Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al We have downloadable decisions or orders for this case
as 1:2023cv00556
Plaintiff: Mylan Pharmaceuticals Inc.
Defendant: Bayer Intellectual Property GMBH, Bayer AG and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Abraxis Bioscience, LLC v. Mylan Pharmaceuticals, Inc.
as 1:2023cv00033
Counter Defendant: Abraxis Bioscience, LLC
Defendant: Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?